— -- Question: What is pramlintide and when is it used? Answer: Pramlitide is a synthetic version of the hormone amylin, which is produced in the pancreas from the same cells that make insulin.

Two separate single-center studies (studies A and B) were carried out. Both studies included adult patients (18-70 years of age) with type 1 DM using short- and long-acting insulin products as ...

The addition of pramlintide, an analog of the naturally-occurring β-cell peptide amylin, before meals improves blood glucose control in patients with type 1 diabetes receiving insulin through an ...

Pramlintide use with insulin has been associated with an increased risk of severe hypoglycemia, particularly in patients with type 1 diabetes. About Xeris Pharmaceuticals, Inc.

ADO09, a co-formulation of pramlintide and insulin A21G, was associated with better glucose levels, improved time in range and more weight loss among people with type 1 diabetes compared with ...

The hormone, pramlintide, marketed under the name Symlin, is currently used to treat diabetes. One team of researchers thinks they may have found a new purpose for it.

Pramlintide, a synthetic analog of amylin, improves postprandial hyperglycemia. We compared subcutaneous (s.c.) pramlintide injection with square wave pramlintide infusion in adolescents with type ...

Following a one-week placebo lead-in period, study subjects were randomized in a balanced fashion to receive twice-daily therapy with one of the following eight treatment regimens: 1) placebo ...

Pramlintide is marketed in the U.S. by Amylin Pharmaceuticals, under the brand name Symlin, to treat diabetes and control blood sugar. Amylin is one of several hormones secreted when eating and ...

Several short-term and long-term clinical trials have shown that the addition of pramlintide to preexisting insulin therapy improved postprandial and overall glycemic control (hemoglobin A 1c ...

(HealthDay) -- The addition of pramlintide, an analog of the naturally-occurring β-cell peptide amylin, before meals improves blood glucose control in patients with type 1 diabetes receiving ...